FDA Staff Suggests Liver Warning on Merck & Co., Inc.'s (JOBS) Cancidas

Reuters -- U.S. Food and Drug Administration staff said on Friday that it would recommend labeling changes for Merck's (MRK.N) Cancidas to warn of possible liver problems in children taking the fungal infection drug.